KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
US
|
NASDAQ
|
KRON
|
Kronos Bio, Inc.
|
US
|
NASDAQ
|
KROS
|
Keros Therapeutics, Inc.
|
US
|
NASDAQ
|
KRTX
|
Karuna Therapeutics, Inc.
|
US
|
NASDAQ
|
KYMR
|
Kymera Therapeutics, Inc.
|
US
|
NASDAQ
|
LABP
|
Landos Biopharma, Inc.
|
US
|
NASDAQ
|
LBPH
|
Longboard Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
LIAN
|
LianBio
|
US
|
NASDAQ
|
LMNL
|
Liminal BioSciences Inc.
|
US
|
NASDAQ
|
LPTX
|
LEAP THERAPEUTICS, INC.
|
US
|
NASDAQ
|
LQDA
|
Liquidia Technologies, Inc.
|
US
|
NASDAQ
|
LSTA
|
Lisata Therapeutics, Inc.
|
US
|
NASDAQ
|
LUMO
|
Lumos Pharma, Inc.
|
US
|
NASDAQ
|
LVTX
|
Lava Therapeutics B.V.
|
US
|
NASDAQ
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
MBIO
|
Mustang Bio, Inc.
|
US
|
NASDAQ
|
MDWD
|
MediWound Ltd.
|
US
|
NASDAQ
|
MDXG
|
MiMedx Group, Inc
|
US
|
NASDAQ
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|